WASHINGTON – The cost of prescription drugs in the United States is too high, but problems, including safety regulations and patent laws, must be ironed out before drugs can be imported from other countries, according to testimony heard by a Senate panel Wednesday. The hearing… Read More
Comments for: Senate panel weighs importation of U.S. drugs
Senate panel weighs importation of U.S. drugs
You may also like
Senate panel weighs importation of U.S. drugs